In an 80‑plus‑year‑old woman who developed new blurry vision one hour after taking metoprolol, apixaban (Eliquis) and furosemide (Lasix) that were started two days ago, should these medications be stopped and an urgent ophthalmology assessment arranged?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Urgent Ophthalmology Referral Required – Likely Medication-Related Blurred Vision

This patient requires urgent ophthalmology evaluation within 24-48 hours to rule out serious ocular pathology, but the blurred vision is most likely medication-related and does not require immediate discontinuation of anticoagulation. The temporal relationship between symptom onset and medication initiation strongly suggests a drug-induced etiology.

Immediate Assessment and Management

Most Likely Culprit: Metoprolol

The timing (symptoms starting 1 hour after taking metoprolol) points most directly to metoprolol as the primary suspect 1. Beta-blockers, particularly lipophilic agents like metoprolol, can cause central nervous system effects including visual disturbances and even visual hallucinations 1, 2. In documented cases, patients experienced visual symptoms that resolved within days of discontinuing metoprolol 1.

Apixaban (Eliquis) Considerations

While apixaban can cause ocular bleeding complications (vitreous hemorrhage, submacular hemorrhage, hyphema), these typically present with more dramatic symptoms than isolated blurred vision 3. The FDA label for Eliquis warns about bleeding risks but does not list blurred vision as a direct adverse effect 4. However, do not abruptly discontinue apixaban without cardiology consultation, as this significantly increases stroke risk in atrial fibrillation patients 4.

Furosemide (Lasix) Role

Furosemide 40 mg can cause transient visual changes through:

  • Electrolyte disturbances affecting ocular function
  • Volume depletion leading to reduced ocular perfusion
  • Potential exacerbation of pre-existing cataracts or glaucoma

Clinical Decision Algorithm

Step 1: Urgent Ophthalmology Referral (Within 24-48 Hours)

  • Rule out acute angle-closure glaucoma (especially in elderly hyperopic women) 5
  • Assess for ocular bleeding (given apixaban use) 3
  • Evaluate for other serious pathology (retinal artery occlusion, optic neuropathy)
  • Document baseline visual acuity and intraocular pressure

Step 2: Medication Review Strategy

Do NOT stop apixaban without cardiology consultation – stroke risk outweighs visual symptom concerns unless ophthalmology identifies active bleeding 4.

Consider switching metoprolol to alternative rate control:

  • Switch to atenolol (less lipophilic, fewer CNS effects) 1
  • Alternative: diltiazem, though note increased bleeding risk when combined with apixaban (particularly doses >120 mg/day) 6, 7
  • If diltiazem used, keep dose ≤120 mg/day to minimize drug interaction with apixaban 6, 7

Step 3: Monitor Electrolytes and Volume Status

  • Check sodium, potassium, creatinine
  • Assess for over-diuresis from furosemide
  • Consider reducing furosemide dose if patient is volume depleted 8

Critical Red Flags Requiring Emergency Evaluation

Refer to emergency department immediately if patient develops:

  • Sudden severe vision loss
  • Eye pain with nausea/vomiting (suggests acute angle-closure glaucoma) 5
  • Floaters, flashing lights, or visual field defects (suggests retinal pathology or bleeding) 3
  • Pupil asymmetry or mid-dilated non-reactive pupil 5

Special Considerations for Elderly Patients

In patients over 80 years old:

  • Higher risk of drug-induced visual disturbances 9
  • Increased susceptibility to beta-blocker CNS effects 1
  • Greater risk of angle-closure glaucoma (hyperopic eyes, shallow anterior chambers) 5
  • Apixaban dosing should be 2.5 mg twice daily if patient meets criteria (age ≥80, weight ≤60 kg, or creatinine ≥1.5 mg/dL) 4

Common Pitfalls to Avoid

  1. Do not discontinue apixaban abruptly – this dramatically increases stroke risk in atrial fibrillation 4
  2. Do not assume "just aging eyes" – new visual symptoms in elderly patients on anticoagulation require ophthalmology evaluation 3
  3. Do not overlook drug interactions – metoprolol combined with other medications can compound visual effects 9
  4. Do not delay ophthalmology referral – while likely medication-related, serious pathology must be excluded 5

Recommended Action Plan

Immediate (Today):

  • Schedule urgent ophthalmology appointment within 24-48 hours
  • Check basic metabolic panel
  • Review apixaban dosing appropriateness for age/weight/renal function
  • Counsel patient NOT to stop any medications without physician guidance

Within 48 Hours (After Ophthalmology Clearance):

  • If no serious ocular pathology found, switch metoprolol to atenolol
  • Consider reducing furosemide if over-diuresed
  • Continue apixaban unless ophthalmology identifies active bleeding

Follow-up (3-7 Days):

  • Reassess visual symptoms after metoprolol switch
  • If symptoms persist, consider alternative etiologies or further medication adjustments

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.